SubjectVerb relationObjectSentenceSentimentTitleUrlDate
Sales of both have been severely constrained by onerous roadblocks to patient access put up by insurers looking to limit spending on expensive drugs Sales of both have been severely constrained by onerous roadblocks to patient access put up by insurers looking to limit spending on the expensive drugs NegativeNEW YORK Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug http://www.reuters.com/news/health/article/us-sanofi-fr-regeneron-cholesterol/sanofi-and-regeneron-cut-list-price-of-cholesterol-drug-by-60-percent-idUSKCN1Q019M2019-02-12